KR840005729A - 스피로〔2h-1, 4-벤조디옥세핀-3(5h)4'-피페리딘 및 3'-피롤리디노〕화합물의 제조방법 - Google Patents

스피로〔2h-1, 4-벤조디옥세핀-3(5h)4'-피페리딘 및 3'-피롤리디노〕화합물의 제조방법 Download PDF

Info

Publication number
KR840005729A
KR840005729A KR1019830003853A KR830003853A KR840005729A KR 840005729 A KR840005729 A KR 840005729A KR 1019830003853 A KR1019830003853 A KR 1019830003853A KR 830003853 A KR830003853 A KR 830003853A KR 840005729 A KR840005729 A KR 840005729A
Authority
KR
South Korea
Prior art keywords
compound
group
formula
hydrogen
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019830003853A
Other languages
English (en)
Korean (ko)
Inventor
쥬니어 레이몬드 더블. 코슬리 (외 1)
Original Assignee
마크 이. 가로트
훽스트-러셀파마슈티칼 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마크 이. 가로트, 훽스트-러셀파마슈티칼 인코포레이티드 filed Critical 마크 이. 가로트
Publication of KR840005729A publication Critical patent/KR840005729A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019830003853A 1982-08-20 1983-08-18 스피로〔2h-1, 4-벤조디옥세핀-3(5h)4'-피페리딘 및 3'-피롤리디노〕화합물의 제조방법 Ceased KR840005729A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/410,155 US4405631A (en) 1982-08-20 1982-08-20 Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'pyrrolidine] compounds and their use as antihypertensive agents
US410155 1995-03-24

Publications (1)

Publication Number Publication Date
KR840005729A true KR840005729A (ko) 1984-11-16

Family

ID=23623465

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830003853A Ceased KR840005729A (ko) 1982-08-20 1983-08-18 스피로〔2h-1, 4-벤조디옥세핀-3(5h)4'-피페리딘 및 3'-피롤리디노〕화합물의 제조방법

Country Status (20)

Country Link
US (1) US4405631A (enExample)
EP (1) EP0102034B1 (enExample)
JP (1) JPS5953489A (enExample)
KR (1) KR840005729A (enExample)
AT (1) ATE33656T1 (enExample)
AU (1) AU576473B2 (enExample)
CA (1) CA1210764A (enExample)
DE (1) DE3376327D1 (enExample)
DK (1) DK381983A (enExample)
ES (2) ES525013A0 (enExample)
FI (1) FI832959A7 (enExample)
GR (1) GR78667B (enExample)
HU (1) HU191874B (enExample)
IL (1) IL69525A0 (enExample)
MA (1) MA19881A1 (enExample)
NO (1) NO833001L (enExample)
NZ (1) NZ205320A (enExample)
PH (1) PH18839A (enExample)
PT (1) PT77223B (enExample)
ZA (1) ZA836127B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521537A (en) * 1982-08-20 1985-06-04 Hoechst-Roussel Pharmaceuticals Incorporated Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds and their use as antihypertensive agents
US4472580A (en) * 1982-08-20 1984-09-18 Hoechst-Roussel Pharmaceuticals Incorporated Spiro (2H-1,4-benzodioxepin-3 (5H)4-piperidine and -3-pyrrolidine) compounds and their use as anti-hypertensive agents
US4751223A (en) * 1986-10-14 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312894A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux composés hétérocycliques à 2 atomes d'oxygène dans le cycle et leur préparation
CH469736A (de) * 1966-06-28 1969-03-15 Geigy Ag J R Verfahren zur Herstellung von neuen Heterospiroalkanen
US3679666A (en) * 1969-04-03 1972-07-25 Hoffmann La Roche 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones

Also Published As

Publication number Publication date
GR78667B (enExample) 1984-09-27
EP0102034A1 (en) 1984-03-07
NO833001L (no) 1984-02-21
PT77223B (en) 1986-03-18
CA1210764A (en) 1986-09-02
AU1816983A (en) 1984-02-23
AU576473B2 (en) 1988-09-01
ATE33656T1 (de) 1988-05-15
DK381983A (da) 1984-02-21
FI832959A0 (fi) 1983-08-18
PH18839A (en) 1985-10-10
DK381983D0 (da) 1983-08-19
ES8505685A1 (es) 1985-06-01
FI832959A7 (fi) 1984-02-21
ES540841A0 (es) 1985-12-01
DE3376327D1 (en) 1988-05-26
MA19881A1 (fr) 1984-04-01
JPS5953489A (ja) 1984-03-28
ES8602800A1 (es) 1985-12-01
IL69525A0 (en) 1983-11-30
ZA836127B (en) 1984-04-25
NZ205320A (en) 1987-05-29
US4405631A (en) 1983-09-20
HU191874B (en) 1987-04-28
EP0102034B1 (en) 1988-04-20
PT77223A (en) 1983-09-01
ES525013A0 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
KR830001928A (ko) 인돌 유도체의 제조방법
EP0823413A3 (en) Benzoheterocyclic compounds
KR840000546A (ko) 이미다조[1,2-a] 피리딘 및 피라진의 제조방법
ES8503666A1 (es) Procedimiento para la preparacion de 1-ariloxi-2,3,4,5-tetrahidro-3-benzazepinas
KR870000301A (ko) N-플루오로피리디늄 염의 제조방법
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
KR830009022A (ko) 벤즈아미도-유도체의 제조방법
KR890006648A (ko) 신규 방법
KR920014781A (ko) N-플루오로피리디늄 염의 제조방법
KR840006009A (ko) 티에노 피리미딘 유도체 및 이의 산부가염의 제조방법
KR840005729A (ko) 스피로〔2h-1, 4-벤조디옥세핀-3(5h)4'-피페리딘 및 3'-피롤리디노〕화합물의 제조방법
ES485593A1 (es) Un procedimiento para la produccion de un derivado de acido fenoxicarboxilico
KR840005449A (ko) 벤조티오 피라노 피리디논
ES538933A0 (es) Un procedimiento para preparar imidazo(1,2-c)pirimidinas
PT75494B (en) Process for the preparation of dibenzymidazoazepine dibenzymidazoxazepine and dibenzymidazothiazepine compounds
ES516552A0 (es) Procedimiento para preparar nuevos derivados de etenilimidazol.
PT968189E (pt) Processo para a preparacao de acidos nicotinicos
KR850007588A (ko) β-나프틸알킬아민의 제조방법
FI883965A0 (fi) Kemiska foereningar.
ES8609233A1 (es) Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos
ES477709A1 (es) Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos.
KR870008838A (ko) 아릴술폰 화합물 제조방법
ES8506606A1 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas
KR840002848A (ko) 유기인산염의 제조방법
KR920007971A (ko) 벤조퀴논 화합물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830818

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19870928

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19830818

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19881121

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19890629

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19881121

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I